General Updates

September 9, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Corporate Relationship Department Plot No. C-1, G- Block, 25, P.J. Towers, Bandra - Kurla Complex, Bandra (East) Dalal Street, Mumbai – 400 051. Mumbai 400 001. Symbol: RPGLIFE Scrip Code: 532983 Dear Sir/Madam, Subject: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’). Further to our letter dated July 29, 2026, informing you about execution of an Investment and Shareholders’ Agreement (IA) amongst the Company, RPGAP, India Life Sciences Fund IV Domestic (ILSF) and Vistaject Fund (VJF) for the proposed issue of shares by its wholly owned subsidiary RPG Active Pharma Limited (“RPGAP”), we wish to inform you that in terms of the said IA, today, on September 9, 2026, RPGAP has allotted securities to ILSF and VJF for a total consideration of INR 243.33 crores constituting 40% of the equity share capital of RPGAP. Post this investment by ILSF and VJF, RPGAP continues to be a subsidiary of the Company. Kindly take the same on records. Yours sincerely, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary